SG Americas Securities
ALT icon

SG Americas Securities’s Altimmune ALT Stock Holding History

SG Americas Securities’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$143K Sell
47,089
-8,536
-15% -$25.5K ﹤0.01% 2937
2026
Q1 		$171K Buy
55,625
+45,050
+426% +$191K ﹤0.01% 2712
2025
Q4 		$38K Sell
10,575
-7,465
-41% -$32.5K ﹤0.01% 3396
2025
Q3 		$68K Buy
+18,040
New +$69.7K ﹤0.01% 3149
2025
Q2 		– Sell
-16,472
Closed -$82K – 2906
2025
Q1 		$82K Sell
16,472
-30,588
-65% -$194K ﹤0.01% 3104
2024
Q4 		$339K Buy
47,060
+12,624
+37% +$96.4K ﹤0.01% 1677
2024
Q3 		$211K Sell
34,436
-220,135
-86% -$1.49M ﹤0.01% 2447
2024
Q2 		$1.69M Buy
254,571
+214,968
+543% +$1.59M 0.01% 1042
2024
Q1 		$403K Buy
39,603
+16,078
+68% +$164K ﹤0.01% 1532
2023
Q4 		$265K Sell
23,525
-19,561
-45% -$81.7K ﹤0.01% 1924
2023
Q3 		$112K Buy
43,086
+16,661
+63% +$47.8K ﹤0.01% 2717
2023
Q2 		$93K Buy
26,425
+11,223
+74% +$50.4K ﹤0.01% 2095
2023
Q1 		$64K Sell
15,202
-8,645
-36% -$103K ﹤0.01% 3023
2022
Q4 		$392K Buy
23,847
+9,785
+70% +$110K ﹤0.01% 1724
2022
Q3 		$180K Buy
14,062
+575
+4% +$8.49K ﹤0.01% 2406
2022
Q2 		$158K Buy
+13,487
New +$83.2K ﹤0.01% 2833
2022
Q1 		– Sell
-13,565
Closed -$124K – 2932
2021
Q4 		$124K Sell
13,565
-13,416
-50% -$143K ﹤0.01% 2940
2021
Q3 		$305K Buy
+26,981
New +$328K ﹤0.01% 2932
2021
Q2 		– Sell
-10,968
Closed -$155K – 2833
2021
Q1 		$155K Buy
10,968
+1,257
+13% +$20.3K ﹤0.01% 2839
2020
Q4 		$110K Buy
+9,711
New +$114K ﹤0.01% 2987
2019
Q4 		– Sell
-13,033
Closed -$25K – 3266
2019
Q3 		$25K Buy
+13,033
New +$28.9K ﹤0.01% 2888
2017
Q2 		– Sell
-445
Closed -$108K – 3157
2017
Q1 		$108K Buy
+445
New +$238K ﹤0.01% 2936
2016
Q4 		– Sell
-73
Closed -$63K – 3106
2016
Q3 		$63K Buy
+73
New +$57.3K ﹤0.01% 3158

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SG Americas Securities's ALT Position: Q2 2026 in Review

SG Americas Securities reduced its Altimmune (ALT) stake by 15% in Q2 2026, selling an estimated $25.5K and leaving 47,089 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #2937.

SG Americas Securities first reported a position in ALT in Q3 2016 and has held it in 23 quarters since. The position peaked at $1.69M in Q2 2024. 211 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • SG Americas Securities held 47,089 shares of Altimmune worth $143K as of Q2 2026.
  • SG Americas Securities sold 8,536 Altimmune shares in Q2 2026, an estimated $25.5K.
  • Altimmune made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2937 holding.
  • SG Americas Securities first reported a position in Altimmune in Q3 2016 and has held it in 23 quarters since.
  • SG Americas Securities's Altimmune position peaked at $1.69M in Q2 2024.
  • 211 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.